An Open Multi-centre Study in Patients With Von Willebrand Disease to Investigate the Pharmacokinetics, Efficacy and Safety of OPTIVATE®, a High Purity, Dual Inactivated Factor VIII and Von Willebrand Factor Concentrate

Trial Profile

An Open Multi-centre Study in Patients With Von Willebrand Disease to Investigate the Pharmacokinetics, Efficacy and Safety of OPTIVATE®, a High Purity, Dual Inactivated Factor VIII and Von Willebrand Factor Concentrate

Discontinued
Phase of Trial: Phase III

Latest Information Update: 21 Apr 2014

At a glance

  • Drugs Factor VIII/von Willebrand factor (Primary)
  • Indications Von Willebrand disease
  • Focus Pharmacokinetics
  • Sponsors Bio Products Laboratory
  • Most Recent Events

    • 21 Apr 2014 Planned End Date changed from 1 Sep 2008 to NULL.
    • 21 Apr 2014 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top